BACKGROUND: Two HPV vaccines prevent infection with HPV-16 and HPV-18, high-risk
(cancer-associated) HPV types which together cause approximately 70% of cervical …

Objectives: Population-level data on prevalence and distribution of human papillomavirus
(HPV) types in the United States are necessary to guide optimal vaccination strategies …

OBJECTIVE: To determine the prevalence of high-risk (cancer-associated) human
papillomavirus (HPV) infection in US women, identify sociodemographic factors associated …

Background. Genital human papillomaviruses (HPV) include> 40 sexually transmitted
viruses. Most HPV infections do not progress to disease, but infection with certain types of …

Objectives The natural history of human papillomavirus (HPV) infection has been studied
extensively in young women; this study investigated HPV infection in adult women. Methods …

Context Human papillomavirus (HPV) infection is estimated to be the most common sexually
transmitted infection. Baseline population prevalence data for HPV infection in the United …

Until recently, awareness of the sexually transmitted infection human papillomavirus—the
virus that causes cervical cancer—was relatively low. The purpose of this study was to …

Background The impact of the prophylactic vaccine against human papillomavirus (HPV)
types 6, 11, 16, and 18 (HPV6/11/16/18) on all HPV-associated genital disease was …

Background: Vaccination against human papillomaviruses (HPV) prevents HPV infections
and, consequently, cervical lesions. However, the effect of vaccination on HPV transmission …

OBJECTIVE: To estimate rates of human papillomavirus (HPV) vaccination, factors
associated with intention and belief in one's ability (self-efficacy) to receive the vaccine, and …